Previous 10 | Next 10 |
home / stock / invvy / invvy news
SLOUGH, England , Nov. 21, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated the preliminary injunction (PI) previously granted against Dr. Reddy's Laboratories (DRL) by...
SLOUGH, England and RICHMOND, Va. , Nov. 19, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that PERSERIS ™ (risperidone) for extended-release injectable suspension is now available in the United States . PERSERIS is approved by the U.S. Food and Drug ...
SLOUGH, United Kingdom and RICHMOND, Va. , Nov. 6, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the following upcoming investor events: Stifel 2018 Healthcare Conference, New York City : On Tuesday, November 13 th from 9:30 a.m. to 10:10 a.m. (loca...
Indivior PLC (INVVY) Q3 2018 Results Earnings Conference Call November 01, 2018 07:00 AM ET Executives Shaun Thaxter - CEO Mark Crossley - CFO Christian Heidbreder - Chief Scientific Officer Javier Rodriguez - Chief Legal Officer Analysts Max Herrmann - Stifel Paul Cudd...
The following slide deck was published by INDIVIOR PLC ADR in conjunction with their 2018 Q3 earnings Read more ...
Indivior PLC ADR ( OTCPK:INVVY ): Q3 Non-GAAP EPS of $0.08; GAAP EPS of $0.12. More news on: INDIVIOR PLC ADR, Earnings news and commentary, Healthcare stocks news, Read more ...
SLOUGH, United Kingdom and RICHMOND, Va. , Nov. 1, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that its financial results for the period ended September 30, 2018 , including the earnings release and investor supplement, are available on the Company's website a...
SLOUGH, England and RICHMOND, Va. , Oct. 24, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") commends Congress and the Administration for passing and enacting H.R. 6, the SUPPORT for Patients and Communities Act of 2018. We further thank the Administr...
President Trump signs the STOP Act today, sweeping bipartisan legislation aimed at addressing the opioid crisis. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news, Read more ...
SLOUGH, U.K. and RICHMOND, Va. , Sept. 26, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today is providing a further update on key business drivers and expectations related to: FY 2018 net revenue and net income guidance; SUBLOCADE™ net revenue development; ...
News, Short Squeeze, Breakout and More Instantly...
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance PR Newswire RICHMOND, Va. , May 23, 2024 /PRNewswire/ -- Indivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, announced that in anticipation o...
Indivior Announces Q1 2024 Financial Results PR Newswire SLOUGH, United Kingdom and RICHMOND, Va. , April 25, 2024 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024 . The earnings re...
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone PR Newswire This head-to-head pharmacodynamic study in healthy volunteers...